Last Updated: November 9, 2026

Patent: 10,307,467

Summary for Patent: 10,307,467

Title:	Use of hyaluronidase for treatment of muscle stiffness
Abstract:	Provided are methods and kits for reducing the severity of muscle stiffness. The method comprises delivering to one or more specific locations in the deep fascia of an affected muscle a composition comprising a therapeutically effective amount of hyaluronidase.
Inventor(s):	Raghavan; Preeti (Brooklyn, NY), Stecco; Antonio (Padua, IT)
Assignee:	New York University (New York, NY)
Application Number:	15/325,938
Patent Claims:	see list of patent claims

Details for Patent 10,307,467

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	May 5, 2004	10,307,467	2035-07-16
Bausch & Lomb Incorporated	VITRASE	hyaluronidase	Injection	021640	December 2, 2004	10,307,467	2035-07-16
Amphastar Pharmaceuticals, Inc.	AMPHADASE	hyaluronidase	Injection	021665	October 26, 2004	10,307,467	2035-07-16
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,307,467

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2015289619	⤷ Start Trial
Canada	2958145	⤷ Start Trial
China	106714824	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.